ImmuCell Corp. (ICCC)
6.46
+0.06
(+0.94%)
USD |
NASDAQ |
Feb 24, 16:00
6.46
0.00 (0.00%)
After-Hours: 16:06
ImmuCell Market Cap : 58.44M for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Becton, Dickinson & Co. | 51.90B |
| Cumberland Pharmaceuticals, Inc. | 58.18M |
| AbbVie, Inc. | 403.97B |
| Precipio, Inc. | 41.61M |
| ACADIA Pharmaceuticals, Inc. | 4.161B |
Market Cap Related Metrics
| PE Ratio | 24.95 |
| PS Ratio | 2.093 |
| Price to Book Value | 1.961 |
| Price to Free Cash Flow | 81.25 |
| Price | 6.46 |
| Earnings Yield | 4.01% |
| Operating PE Ratio | 24.96 |
| Normalized PE Ratio | 24.95 |